Marianne De Backer Arrowhead Pharmaceuticals, Inc. (ARWR) insider trading activity

Marianne De Backer is Director of ARROWHEAD PHARMACEUTICALS, INC.. Currently has a direct ownership of 31,267 shares of ARWR, which is worth approximately $699,442. The most recent transaction as insider was on Jan 10, 2023, when has been sold 7,867 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 31.3K

0% 3M change

0% 12M change

Total Value Held $699,442

Marianne De Backer Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 10 2023	BUY Grant, award, or other acquisition	-	7,867 Added 20.1%	31,267 Common Stock
Jan 07 2022	BUY Grant, award, or other acquisition	-	6,400 Added 21.48%	23,400 Common Stock
Jan 03 2022	SELL Open market or private sale	$293,265 $65.17 p/Share	4,500 Reduced 20.93%	17,000 Common Stock
Jun 24 2021	SELL Open market or private sale	$449,250 $89.85 p/Share	5,000 Reduced 18.87%	21,500 Common Stock
Jan 01 2021	BUY Grant, award, or other acquisition	-	9,000 Added 25.35%	26,500 Common Stock
Oct 08 2020	BUY Open market or private purchase	$50,470 $50.47 p/Share	1,000 Added 5.41%	17,500 Common Stock

Also insider at

KRON

Kronos Bio, Inc. Healthcare

Director

VIR

Vir Biotechnology, Inc. Healthcare

Chief Executive Officer

MDB